ReviewInternational journal of nanomedicine2026
How Emerging Nanomaterials are Effective in Bone Regeneration?
Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bone defects remain challenging due to microenvironment disruption and immune imbalance. Traditional grafts offer structural support; however, they do not actively modulate this pathological niche. This review underscores smart nanomaterial reservoirs for bone regeneration, focusing on their capacity to remodel the hostile microenvironment and restore immune homeostasis. Key pathophysiological barriers, including vascular disruption, macrophage imbalance, and oxidative stress-induced ferroptosis, are identified as therapeutic targets. Additionally, fundamental nanoscale building blocks (rigid inorganic, polymeric, and inorganic piezoelectric materials) are critically compared, with an expanded focus on emerging technologies such as versatile nanofibers and 3D-printable bio-ink formulations. These components can be assembled into smart reservoirs (hydrogels, exosomes, and 3D scaffolds), enabling stimuli-responsive therapeutic delivery (pH, reactive oxygen species, and enzymes). By reprogramming intercellular communication and promoting M1-to-M2 macrophage polarization, these reservoirs restore osteoimmune homeostasis and couple osteogenesis with angiogenesis. Finally, translational challenges and future directions toward dynamically adaptive nanomedicines are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.